EU approves its first vaccine for common respiratory virus RSV European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually. Natalie Grover,Eva Mathews Reuters

...

The shot, called Arexvy, is made by British drugmaker GSK (GSK.L) and is designed to protect people aged 60 and over.

...